CurveBeam received FDA 510(k) marketing clearance for its LineUP multi-extremity weight bearing CT system. The system allows radiologists and orthopedic...
CathWorks announced that its FFRangio System received FDA 510(k) clearance. The FFRangio system demonstrated accuracy versus the invasive FFR wire...
GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, announced a partnership with the United Kingdom’s (UK) National Health Service (NHS) to help transform cancer outcomes by making GRAIL’s multi-cancer early detection blood test, Galleri , available to UK patients starting in 2021.
Doctors involved in a multi-centre clinical study for the treatment of Post-Stroke Shoulder Pain have made the first implantation of...
Hologic featured its next-generation MammoSite ML (multi-lumen) radiation therapy system at the American Society of Radiation Oncology (ASTRO) meeting. By...
The primary objective of the study is to compare the ability to consume foods without dose-limiting symptoms during a double-blind placebo-controlled food challenge (DBPCFC), after treatment with either omalizumab or placebo for omalizumab.
Second Sight Medical announced positive three year results post-implant of its Argus II Retinal Prosthesis System from a multi-center clinical...
Aspire Bariatrics announced the publication of 201-patient, multi-center post-market European registry study of the AspireAssist System for obesity in the...
Patient treatments have begun in the multi-centre REDUCE-HTN renal denervation clinical study of the Vessix V2 Renal Denervation System, from...
Mallinckrodt Pharmaceuticals announced interim analysis results of its company-sponsored, Phase III, single-arm, open-label, multi-center study assessing the efficacy of treating...